Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Australian mortgage brokers end 2025 with rate cuts, bank shake-ups and an AI push — here’s what stood out

Australian mortgage brokers end 2025 with rate cuts, bank shake-ups and an AI push — here’s what stood out

Australian mortgage brokers ended 2025 with record market share and momentum from falling interest rates, despite tighter lending rules and increased regulatory scrutiny. Major banks restricted company and trust lending, while ANZ expanded proprietary lending. Industry podcasts tracked themes of technology, broker relevance, and housing outlook. The October–December quarter saw unpredictable lending decisions and regulatory pressure.
AI stocks today: Nvidia’s China H200 chip rush puts chipmakers in focus before New Year trade

AI stocks today: Nvidia’s China H200 chip rush puts chipmakers in focus before New Year trade

Nvidia has asked TSMC to increase production of its H200 AI chips as Chinese firms ordered over 2 million units for 2026, far above Nvidia’s inventory, sources told Reuters. TSMC may ramp up output in Q2 2026 if China approves imports after new U.S. export rules. Nvidia shares fell 0.3% Tuesday. ByteDance plans to spend $14.3 billion on Nvidia chips in 2026, according to the South China Morning Post.
EQT stock wobbles premarket as U.S. natural gas futures slide after weather-driven rally

EQT stock wobbles premarket as U.S. natural gas futures slide after weather-driven rally

U.S. natural gas futures fell about 4% early Wednesday to $3.81/mmBtu after a recent surge on colder forecasts and record LNG export demand. EQT Corp shares slipped 0.5% in extended trading, last quoted at $54.36. Average gas flows to U.S. LNG export plants hit 18.5 bcfd so far in December, topping November’s record, LSEG data showed. Investors are watching winter forecasts and upcoming February earnings reports.
XRP price today: Token holds near $1.87 as U.S. XRP ETF inflows extend streak into year-end

XRP price today: Token holds near $1.87 as U.S. XRP ETF inflows extend streak into year-end

XRP traded near $1.87 early Wednesday, up 0.5%, as U.S. spot XRP ETFs logged a 29th straight session of net inflows, totaling $1.15 billion since launch. Bitcoin and ether also rose, while XRP funds drew money even as bitcoin and ether funds saw outflows in December. The 21Shares XRP ETF registration became effective Dec. 10, SEC filings showed. Traders are watching the $2 resistance level amid thin holiday liquidity.
31 December 2025
Dow Jones today: Fed minutes and thin liquidity set the tone for 2025’s final session

Dow Jones today: Fed minutes and thin liquidity set the tone for 2025’s final session

The Dow closed down 94.87 points, or 0.20%, at 48,367.06 in thin holiday trading Tuesday. Federal Reserve minutes showed policymakers split after a quarter-point rate cut, keeping attention on the 2026 rate outlook. Boeing secured an $8.6 billion Pentagon contract tied to the F-15 Israel Program. U.S. bond markets will close early at 2 p.m. ET Wednesday; stocks are shut Thursday for New Year’s Day.
SRRK stock drops 3% today: What’s driving Scholar Rock shares as FDA reinspection nears

SRRK stock drops 3% today: What’s driving Scholar Rock shares as FDA reinspection nears

Scholar Rock shares fell 3.2% to $43.76 Tuesday afternoon, underperforming biotech peers as investors watched for updates on FDA reinspection timing for its lead drug, apitegromab. The company aims to resubmit its biologics license application in 2026 after the Indiana fill-finish site, now owned by Novo Nordisk, completes remediation and is reinspected by year-end 2025.
30 December 2025
GRAIL stock drops in New York session as Galleri FDA filing timeline returns to focus

GRAIL stock drops in New York session as Galleri FDA filing timeline returns to focus

GRAIL shares dropped 3.3% to $84.95 Tuesday afternoon, extending a two-day slide. An Oregon Health & Science University release highlighted PATHFINDER 2 data and confirmed a first-quarter 2026 FDA submission for Galleri. Investors await management’s Jan. 12 update at the J.P. Morgan Healthcare Conference. The stock is down 7.2% since Friday’s close.
TIC Solutions (TIC) stock slides 3.5% today as Fed minutes and thin year-end trade set the tone

TIC Solutions (TIC) stock slides 3.5% today as Fed minutes and thin year-end trade set the tone

NEW YORK, December 30, 2025, 15:14 ET — Regular session Shares of TIC Solutions, Inc. (TIC) fell about 3.5% to $10.02 in afternoon trading on Tuesday, underperforming a largely steady U.S. equity market. The stock last closed at $10.38. The decline came in holiday-thin trade as investors recalibrated rate expectations after the Federal Reserve’s December-meeting minutes hit the tape. “At the end of the day, solid corporate profits can make up for a lot of sins,” said Ryan Detrick, chief market strategist at Carson Group. Reuters The slide matters for TIC because investors have been focused on execution rather than
Why Travere Therapeutics (TVTX) stock is down today as insider sales hit the tape ahead of a key FDA date

Why Travere Therapeutics (TVTX) stock is down today as insider sales hit the tape ahead of a key FDA date

Travere Therapeutics shares fell 3.8% to $37.39 Tuesday afternoon, outpacing declines in biotech ETFs. SEC filings showed Chief Medical Officer Jula Inrig and Chief Commercial Officer Pieter Heerma sold shares on Dec. 24 under pre-arranged 10b5-1 plans. The moves come weeks before a key FDA decision on Filspari for FSGS, set for Jan. 13, 2026. Trading volume reached about 893,000 shares.
30 December 2025
1 291 292 293 294 295 539

Stock Market Today

Alphabet stock sinks on AI spending fears — what to watch for Google shares next week

Alphabet stock sinks on AI spending fears — what to watch for Google shares next week

8 February 2026
Alphabet shares fell 2.5% to $322.86 Friday, lagging a broader tech rally as investors reacted to reports the company may double AI infrastructure spending this year. The Dow closed above 50,000 for the first time. Wall Street is shifting focus from AI demos to cash flow, putting pressure on Big Tech. Key U.S. jobs and inflation data are expected this week.
Palantir stock rebounds into the weekend — what could move PLTR next week

Palantir stock rebounds into the weekend — what could move PLTR next week

8 February 2026
Palantir shares closed up 4.5% at $135.90 on Friday after a volatile week, rebounding from earlier double-digit losses. The stock swung sharply following its quarterly report, which showed Q4 revenue up 70% to $1.41 billion and a 2026 forecast of up to $7.2 billion. Director Alexander D. Moore sold 20,000 shares on Feb. 2, SEC filings show. UK officials are calling for a pause on Palantir’s NHS and defense contracts.
Kenvue stock price holds near $18 as KVUE heads into a dividend date and Feb. 17 results

Kenvue stock price holds near $18 as KVUE heads into a dividend date and Feb. 17 results

8 February 2026
Kenvue shares closed at $18.13 on Friday, about $1 below the implied $19.15 value of Kimberly-Clark’s pending cash-and-stock takeover. Shareholders of both companies overwhelmingly approved the deal, which is expected to close in the second half of 2026 pending regulatory review. Kenvue will report earnings on Feb. 17 without a conference call. The board declared a $0.2075 dividend, payable Feb. 25.
Bitmine Immersion Technologies stock jumps 18% into weekend as crypto steadies — what to watch Monday

Bitmine Immersion Technologies stock jumps 18% into weekend as crypto steadies — what to watch Monday

8 February 2026
Bitmine Immersion Technologies shares jumped 17.6% to $20.47 Friday, rebounding after four days of losses. Bitcoin and ether both surged over 10%, but demand for downside protection in crypto options remained high. Bitmine’s stock tracked crypto moves closely, reflecting its large ether and bitcoin holdings. About 74 million Bitmine shares traded in a session that saw the stock swing between $18.70 and $20.70.
Go toTop